Source:http://linkedlifedata.com/resource/pubmed/id/19029132
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2008-12-5
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
1462-0332
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
48
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2-4
|
| pubmed:meshHeading |
pubmed-meshheading:19029132-Drug Evaluation, Preclinical,
pubmed-meshheading:19029132-Fibrosis,
pubmed-meshheading:19029132-Humans,
pubmed-meshheading:19029132-Piperazines,
pubmed-meshheading:19029132-Protein Kinase Inhibitors,
pubmed-meshheading:19029132-Pulmonary Fibrosis,
pubmed-meshheading:19029132-Pyrimidines,
pubmed-meshheading:19029132-Treatment Outcome
|
| pubmed:year |
2009
|
| pubmed:articleTitle |
Imatinib as a novel therapeutic approach for fibrotic disorders.
|
| pubmed:publicationType |
Editorial,
Comment
|